Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
2.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
3.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
4.

Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.

Kelly A, Bartlett SJ, de Wit MP, Beaton DE, Dawson T, Evans V, Gill M, Hassett G, March L, Scholte-Voshaar M, Singh JA, Tong A, Tugwell P, Wong P, Tymms K.

J Rheumatol. 2019 Jan 15. pii: jrheum.181078. doi: 10.3899/jrheum.181078. [Epub ahead of print]

PMID:
30647162
5.

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.

Tunis SR, Maxwell LJ, Graham ID, Shea BJ, Beaton DE, Bingham CO 3rd, Brooks P, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2017 Oct;44(10):1551-1559. doi: 10.3899/jrheum.161273. Epub 2017 Aug 1.

6.

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Petkovic J, Barton JL, Flurey C, Goel N, Bartels CM, Barnabe C, de Wit MPT, Lyddiatt A, Lacaille D, Welch V, Boonen A, Shea B, Christensen R, Maxwell LJ, Campbell W, Jull J, Toupin-April K, Singh JA, Goldsmith CH, Sreih AG, Pohl C, Hofstetter C, Beaton DE, Buchbinder R, Guillemin F, Tugwell PS.

J Rheumatol. 2017 Nov;44(11):1727-1733. doi: 10.3899/jrheum.160975. Epub 2017 Feb 15.

7.

Changes in the clinical presentation of patients with rheumatoid arthritis from the early 1990s to the years 2010: earlier identification but more severe patient reported outcomes.

Nieuwenhuis WP, de Wit MP, Boonen A, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):2054-2056. doi: 10.1136/annrheumdis-2016-209949. Epub 2016 Aug 24. No abstract available.

PMID:
27558985
8.

Commentary: Patients as Partners: Building on the Experience of Outcome Measures in Rheumatology.

Kirwan JR, de Wit MP, Bingham CO 3rd, Leong A, Richards P, Tugwell P, Voshaar M, Gossec L; Outcome Measures in Rheumatology Executive Committee.

Arthritis Rheumatol. 2016 Jun;68(6):1334-6. doi: 10.1002/art.39678. No abstract available.

9.
10.

What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?

de Wit MP, Abma TA, Koelewijn-van Loon MS, Collins S, Kirwan J.

J Rheumatol. 2014 Jan;41(1):177-84. doi: 10.3899/jrheum.130816. Epub 2013 Oct 15.

PMID:
24128777
11.

"If i wasn't this robust": patients' expectations and experiences at the Outcome Measures in Rheumatology Conference 2010.

de Wit MP, Koelewijn-van Loon MS, Collins S, Abma TA, Kirwan J.

Patient. 2013;6(3):179-87. doi: 10.1007/s40271-013-0017-0.

PMID:
23736943
12.

System dynamic modelling to assess economic viability and risk trade-offs for ecological restoration in South Africa.

Crookes DJ, Blignaut JN, de Wit MP, Esler KJ, Le Maitre DC, Milton SJ, Mitchell SA, Cloete J, de Abreu P, Fourie nee Vlok H, Gull K, Marx D, Mugido W, Ndhlovu T, Nowell M, Pauw M, Rebelo A.

J Environ Manage. 2013 May 15;120:138-47. doi: 10.1016/j.jenvman.2013.02.001. Epub 2013 Mar 22.

PMID:
23524327
13.

Do not forget the professional--the value of the FIRST model for guiding the structural involvement of patients in rheumatology research.

de Wit MP, Elberse JE, Broerse JE, Abma TA.

Health Expect. 2015 Aug;18(4):489-503. doi: 10.1111/hex.12048. Epub 2013 Jan 31.

14.

The importance of patient participation in measuring rheumatoid arthritis flares.

Bingham CO 3rd, Alten R, de Wit MP.

Ann Rheum Dis. 2012 Jul;71(7):1107-9. doi: 10.1136/annrheumdis-2011-200870. Epub 2012 Feb 9. No abstract available.

PMID:
22323439
15.

Shared decision making: really putting patients at the centre of healthcare.

Stiggelbout AM, Van der Weijden T, De Wit MP, Frosch D, Légaré F, Montori VM, Trevena L, Elwyn G.

BMJ. 2012 Jan 27;344:e256. doi: 10.1136/bmj.e256.

PMID:
22286508
16.

Treating rheumatoid arthritis to target: the patient version of the international recommendations.

de Wit MP, Smolen JS, Gossec L, van der Heijde DM.

Ann Rheum Dis. 2011 Jun;70(6):891-5. doi: 10.1136/ard.2010.146662. Epub 2011 Apr 7.

17.

European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects.

de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, Da Silva JA, Glüsing B, Gossec L, Hewlett S, Jongkees M, Magnusson D, Scholte-Voshaar M, Richards P, Ziegler C, Abma TA.

Ann Rheum Dis. 2011 May;70(5):722-6. doi: 10.1136/ard.2010.135129. Epub 2011 Jan 20.

PMID:
21257615

Supplemental Content

Loading ...
Support Center